FDA Adverse Event Injury Summary report: N

SIG MOD TIB TRAY CEM COCR 2.5

MDR report key: 3844011 · Received June 2, 2014

Report

Report Number
1818910-2014-19918
Event Type
Injury
Date Received
June 2, 2014
Date of Event
May 6, 2014
Report Date
May 6, 2014
Manufacturer
DEPUY (IRELAND) 9616671
Product Code
JWH
PMA / PMN Number
PK032151
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

Additional Manufacturer Narrative · 1

ADDITIONAL NARRATIVE: THE DEVICES ASSOCIATED WITH THIS REPORT WERE NOT RETURNED. A COMPLAINT DATABASE SEARCH FINDS NO OTHER REPORTED INCIDENTS AGAINST THE PROVIDED PRODUCT AND LOT COMBINATION. REVIEW OF THE DEVICE HISTORY RECORDS AND/OR A LOT SPECIFIC COMPLAINT DATABASE SEARCH WAS NOT POSSIBLE FOR THE CEMENT AS THE PRODUCT AND LOT CODE REQUIRED WAS NOT PROVIDED. REQUESTS FOR ADDITIONAL INVESTIGATIONAL INPUTS WERE MADE IN ACCORDANCE WITH WI-7915 APPENDIX A. NO ADDITIONAL INFORMATION WAS OBTAINED. THE INVESTIGATION COULD NOT VERIFY OR IDENTIFY ANY PRODUCT CONTRIBUTION TO THE REPORTED EVENT WITH THE INFORMATION PROVIDED. BASED ON THE INABILITY TO IDENTIFY ROOT CAUSE, THE NEED FOR CORRECTIVE ACTION WAS NOT INDICATED. DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD ADDITIONAL INFORMATION BE RECEIVED, THE INFORMATION WILL BE REVIEWED AND THE INVESTIGATION WILL BE RE-OPENED AS NECESSARY.

Description of Event or Problem · 1

PATIENT WAS REVISED BECAUSE OF A LOOSE TIBIAL TRAY. LOOSENING OCCURRED AT THE CEMENT/IMPLANT INTERFACE. THE CEMENT WAS DEPUY MANUFACTURED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
321622 SIG MOD TIB TRAY CEM COCR 2.5 KNEE TIBIAL TRAY JWH DEPUY (IRELAND) 9616671 3496880

Patients

Seq Age Sex Outcome Treatment
1 67 YR Required Intervention